Crinetics Pharmaceuticals total liabilities and share holders equity for the quarter ending September 30, 2024 was $0.937B, a 46.11% increase year-over-year.
Crinetics Pharmaceuticals total liabilities and share holders equity for 2023 was $0.635B, a 80.41% increase from 2022.
Crinetics Pharmaceuticals total liabilities and share holders equity for 2022 was $0.352B, a 0.33% increase from 2021.
Crinetics Pharmaceuticals total liabilities and share holders equity for 2021 was $0.351B, a 91.35% increase from 2020.
Crinetics Pharmaceuticals Total Liabilities and Share Holders Equity 2017-2024 | CRNX